期刊文献+

甲硫氨酰氨肽酶的研究进展 被引量:3

Advances in the study of methionine aminopeptidases
下载PDF
导出
摘要 目的 总结近年来甲硫氨酰氨肽酶作为抗肿瘤、抗感染药物靶点的研究进展。方法 查阅近几年国内外有关文献资料并进行分析综述。结果 人源Ⅱ型甲硫氨酰氨肽酶是抗肿瘤血管生成药物TNP-470在细胞内的分子靶点,细菌和真菌体内的甲硫氨酰氨肽酶可以作为抗感染药物的靶点。结论 研究甲硫氨酰氨肽酶及其抑制剂对于发现新型抗肿瘤和抗感染药物有重要意义。
出处 《中国药学杂志》 CAS CSCD 北大核心 2004年第11期804-808,共5页 Chinese Pharmaceutical Journal
基金 国家自然科学基金(30271528)上海市青年科技启明星计划资助项目(02QB14013)
  • 相关文献

参考文献1

二级参考文献29

  • 1Bradshaw RA, Brickey WW, Walker KW. N-terminal processing: the methionine aminopeptidase and N alphaacetyl transferase families. Trends Biochem Sci 1998; 23:263 -7. 被引量:1
  • 2Lowther WT, Matthewsi BW. Structure and function of the methionine aminopeptidases. Biochem Biophys Acta 2000;1477: 157-67. 被引量:1
  • 3Arfin SM, Kendall RL, Bradshaw RA. Eukaryotic methionyl aminopeptidases: two classes of cobalt-dependent enzymes.Proc Natl Acad Sci USA 1995: 92:7714-8. 被引量:1
  • 4Lowther WT, Orville AM, Madden DT, Lim S, Rich DH,Matthews BW. Escherichia coil methionine aminopeptidase: implications of crystallographic analyses of the native, mutant, and inhibited enzymes for the mechanism of catalysis. Biochemistry 1999; 38: 7678-88. 被引量:1
  • 5Liu S, Widom J, Kemp CW, Crews CM, Clardy J. Structure of human methionine aminopeptidase-2 complexed with fumazillin. Science 1998; 282: 1324-7. 被引量:1
  • 6Tahirov TH, Oki H, Tsukihara T, Ogasahara K, Yutani K,Ogata K, et al. Crystal structure of methionine aminopeptidase from hyperthermophile, Pyrococcus furiosus. J Mol Biol 1998; 284:101-24. 被引量:1
  • 7Walker KW, Bradshaw RA. Yeast methionine aminopeptidase I can utilize either Zn2. or Co2. as a cofactor: a case of mistaken identity? Protein Sci 1998; 7: 2684-7. 被引量:1
  • 8D'souza VM, Holz RC. The methionyl aminopeptidase from Escherichia coli can function as an iron(Ⅱ) enzyme. Biochemistry 1999; 38:11079-85. 被引量:1
  • 9Meng L, Ruebush S, D'souza VM, Copik A J, Tsunasawa S,Holz RC. Overexpression and divalent metal binding properties of the methionyl aminopeptidase from Pyrococcus furiosus. Biochemistry 2002; 41: 7199-208. 被引量:1
  • 10D'souza VM, Swierczek SI, Cosper NJ, Meng L, Ruebush S,Copik A J, et al. Kinetic and structural characterization of manganese (Ⅱ)-loaded methionyl aminopeptidases. Biochemistry 2002; 41: 13096-105. 被引量:1

同被引文献58

  • 1王敏,张月琴.以组织蛋白酶K为靶点的新药筛选[J].中国抗生素杂志,2005,30(6):373-379. 被引量:3
  • 2王长云,邵长伦.海洋药物学[M].北京:科学出版社,2011:204-344. 被引量:4
  • 3Singh J,Petter R C,Baillie T A,et al. The resurgence of co valent drugs[J].Nat Rev Drug Diseov, 2012, 10(4): 307- 317. 被引量:1
  • 4Hadvary P,Sidler W,et al. The Lipase Inhibitor Tetrahydro- lipstatin Binds Covalently to the Putative Active Site Serine of Pancreatic Lipase [J]. Biol Chem, 1991,266 ( 4 ) : 2021- 2027. 被引量:1
  • 5Zhi J, Melia A T, Eggers H, et al. Review of limited systemic absorption of orlistat, a lipase inhibitor, in healthy human volunteers[J]. J Clin Pharmacol, 1995,35 : 1103-1108. 被引量:1
  • 6Fako V E,Zhang J, Liu J. Mechanism of ()rlistat Hydrolysis by the Thioesterase of Human Fatty Acid Synthase [J].ACS Catal, 2014,4 : 3444-3453. 被引量:1
  • 7Pernhle C W,Johnson L C,and Lowther W T. Crystal struc- ture of the thioesterase domain of human fatty acid synthase inhibited by Orlistat[J].Nat Struct Mol Biol,2007, 14:704- 709. 被引量:1
  • 8Peters J U. 11 Years of Cyanopyrrolidines as DPP-IV Inhibi- tors [J].Curt Top Med Chem,2007,7(6):579-595. 被引量:1
  • 9Metzler W J, Yanchunas J,Weigelt C, et al. Involvement of DPP-IV catalytic residues in enzyme - saxagliptin complex formatio[J]. Protein Science, 2008,17 : 240-250. 被引量:1
  • 10Chen K X, Njoroge F G. The journey to the discovery of bo- ceprevir:an NSa-NS4 HCV protease inhibitor for the treat- ment of chronic hepatitis C[J]. Progress in Medicinal Chemistry, 2010,49 : 146. 被引量:1

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部